Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0021051 (immunodeficiency)
 71,517 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In an attempt to understand the mechanisms of immunodeficiency induced by human T lymphotropic virus type I (HTLV-I), HSV-specific CD4+ human multifunctional T cell clones were infected with HTLV-I in vitro. Early after HTLV-I infection, when their growth was still IL-2-dependent, clones were found to have almost completely lost their cytotoxic activity. At that time, their HSV-Ag-induced proliferative response and helper function for anti-HSV antibody production by B cells were only partially impaired. After this initial phase, the HTLV-I-infected clone became IL-2-independent, and the helper function was also completely lost. IL-2-dependent HTLV-I-infected clones showed degrees of proliferative response and elevation of intracellular free Ca2+ concentration induced by anti-CD3 mAb equivalent to those of HTLV-I-uninfected clones. On the other hand, during the IL-2-independent stage, expression of CD3-TCR complex on the cell surface was markedly decreased, and no significant elevation of intracellular free Ca2+ concentration was detected in response to anti-CD3 mAb. These data indicated that the loss of cytotoxic activity of HSV-specific T cell clones observed early after HTLV-I infection was not the result of impaired antigen recognition via the CD3-TCR complex, but might be due to dysfunction in the effector phase. On the other hand, the dysfunction of helper activity found late after HTLV-I infection might have mainly occurred in the recognition phase due to the decreased expression of CD3-TCR complex. The present data appear to suggest certain aspects of the pathogenesis of the immunodeficiency occurring in HTLV-I infection.
 ...
PMID:Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T lymphotropic virus type I. 247 28

Tyrosine phosphorylation of cellular proteins is a critical early event in the T-cell activation process induced by the antigenic peptide or monoclonal antibodies specific for the CD3 T-cell receptor (TCR) complex. Phosphoproteins are currently detected by Western blotting experiments or, recently, by labelling intracellular proteins with an antiphosphotyrosine monoclonal antibody and flow cytometric analysis (Farahi Far et al.: Cytometry 15:327-334, 1994; Vuillier et al.: J Immunol Methods 185:43-56, 1995). Here, we describe improvements of these latter methods in order to study selectively the CD3-TCR signaling pathway of patients with immunodeficiency diseases or lymphopenia. This new technique quantifies tyrosine-phosphorylated proteins in in vitro-activated T-cell subsets directly on whole blood samples. The stimulation of the CD3-TCR complex induces a specific and significant increase in the phosphotyrosine fluorescence intensity in both CD4 and CD8 subpopulations. The simplicity and the good reproducibility of this method make it particularly convenient for laboratory routine evaluation, and the use of very small volumes of blood is well adapted to the study of immunodepressed patients. Moreover, this technique allows the detection of early molecular defects of the CD3-TCR signal-transduction pathway.
 ...
PMID:Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples. 929 15